Zobrazeno 1 - 10
of 32
pro vyhledávání: '"H. J. H. van der Pal"'
Autor:
A. J. M. Meijer, F. A. Diepstraten, T. Langer, L. Broer, I. K. Domingo, E. Clemens, A. G. Uitterlinden, A. C. H. de Vries, M. van Grotel, W. P. Vermeij, R. A. Ozinga, H. Binder, J. Byrne, E. van Dulmen-den Broeder, M. L. Garrè, D. Grabow, P. Kaatsch, M. Kaiser, L. Kenborg, J. F. Winther, C. Rechnitzer, H. Hasle, T. Kepak, K. Kepakova, W. J. E. Tissing, A. L. F. van der Kooi, L. C. M. Kremer, J. Kruseova, S. M. F. Pluijm, C. E. Kuehni, H. J. H. van der Pal, R. Parfitt, C. Spix, A. Tillmanns, D. Deuster, P. Matulat, G. Calaminus, A. E. Hoetink, S. Elsner, J. Gebauer, R. Haupt, H. Lackner, C. Blattmann, S. J. C. M. M. Neggers, S. R. Rassekh, G. E. B. Wright, B. Brooks, A. P. Nagtegaal, B. I. Drögemöller, C. J. D. Ross, A. P. Bhavsar, A. G. am Zehnhoff-Dinnesen, B. C. Carleton, O. Zolk, M. M. van den Heuvel-Eibrink, the PanCareLIFE Consortium, and the CPNDS Consortium
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893
Externí odkaz:
https://doaj.org/article/1a21ee1f4f0440f184693f4b2b482abf
Autor:
Wim J. E. Tissing, J Kruseova, A E Hoetink, G Calaminus, R Haupt, I K Domingo, E van Dulmen-den Broeder, Amit P. Bhavsar, J Byrne, H Hasle, C Spix, S Elsner, A P Nagtegaal, L Kenborg, J Gebauer, O Zolk, S M F Pluijm, A J M Meijer, H Binder, R A Ozinga, C Rechnitzer, S J C M M Neggers, M L Garrè, P Matulat, D Deuster, T Langer, Britt I. Drögemöller, H. J. H. van der Pal, D Grabow, Leontien C. M. Kremer, Galen E.B. Wright, E Clemens, A.L.F. van der Kooi, M Kaiser, Bruce Carleton, F A Diepstraten, J F Winther, C Blattmann, L Broer, M van Grotel, R Parfitt, A G Am Zehnhoff-Dinnesen, K Kepakova, H Lackner, M M van den Heuvel-Eibrink, Shahrad Rod Rassekh, T Kepak, A. C. H. de Vries, Beth Brooks, André G. Uitterlinden, C. E. Kuehni, A Tillmanns, Wilbert P. Vermeij, Colin J. D. Ross, P Kaatsch
Publikováno v:
37. Wissenschaftliche Jahrestagung der Deutschen Gesellschaft für Phoniatrie und Pädaudiologie (DGPP); 20210917-20210918; sine loco [digital]; DOCP15 /20211028/
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Background: Ototoxicity (hearing loss, tinnitus and/or vertigo) is a serious adverse event of cisplatin treatment in children with cancer. The heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b1abb74a67b5c6ca531ead07151865
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
Autor:
Wim J. E. Tissing, Martha A. Grootenhuis, Dorine Bresters, L.M.E. van Erp, A C de Vries, Cécile M. Ronckers, A.L.L.F. van der Kooi, H. J. H. van der Pal, M. van den Berg, M. van Gorp, Marloes Louwerens, Jacqueline J. Loonen, L. C. M. Kremer, Heleen Maurice-Stam, E. van Dulmen-den Broeder, M. Van der Heiden-van der Loo, Birgitta Versluys, M.M. van den Heuvel-Eibrink
Publikováno v:
European Journal of Cancer, 152, 204-214. Pergamon
European Journal of Cancer, 152, 204-214. ELSEVIER SCI LTD
European Journal of Cancer, 152, 204-214
European Journal of Cancer, 152, 204-214. Elsevier Ltd.
van Erp, L M E, Maurice-Stam, H, Kremer, L C M, Tissing, W J E, van der Pal, H J H, de Vries, A C H, van den Heuvel-Eibrink, M M, Versluys, B A B, Loonen, J J, Bresters, D, Louwerens, M, van der Heiden-van der Loo, M, van den Berg, M H, Ronckers, C M, van der Kooi, A L L F, van Gorp, M, van Dulmen-den Broeder, E & Grootenhuis, M A 2021, ' Health-related quality of life in Dutch adult survivors of childhood cancer: A nation-wide cohort study ', European Journal of Cancer, vol. 152, pp. 204-214 . https://doi.org/10.1016/j.ejca.2021.04.033
European Journal of Cancer, 152, pp. 204-214
European Journal of Cancer, 152, 204-214. ELSEVIER SCI LTD
European Journal of Cancer, 152, 204-214
European Journal of Cancer, 152, 204-214. Elsevier Ltd.
van Erp, L M E, Maurice-Stam, H, Kremer, L C M, Tissing, W J E, van der Pal, H J H, de Vries, A C H, van den Heuvel-Eibrink, M M, Versluys, B A B, Loonen, J J, Bresters, D, Louwerens, M, van der Heiden-van der Loo, M, van den Berg, M H, Ronckers, C M, van der Kooi, A L L F, van Gorp, M, van Dulmen-den Broeder, E & Grootenhuis, M A 2021, ' Health-related quality of life in Dutch adult survivors of childhood cancer: A nation-wide cohort study ', European Journal of Cancer, vol. 152, pp. 204-214 . https://doi.org/10.1016/j.ejca.2021.04.033
European Journal of Cancer, 152, pp. 204-214
Aim: To investigate the health-related quality of life (HRQOL) of Dutch adult childhood cancer survivors (CCS) and to identify risk factors of impaired HRQOL.Methods: Adult CCS (age >18, diagnosed = 5 years since diagnosis) from the Dutch LATER regis
Autor:
H. J. H. van der Pal, Wouter E.M. Kok, Milanthy S. Pourier, L. C. M. Kremer, Annelies M. C. Mavinkurve-Groothuis, Yigal M. Pinto, Louise Bellersen, Jacqueline J. Loonen, Jan M. Leerink, E.A.M Feijen, Livia Kapusta, Paola G. Meregalli, E. C. van Dalen, Remy Merkx
Publikováno v:
European Heart Journal. 41
Background Childhood cancer survivors (CCS) treated with anthracyclines and/or chest-directed radiotherapy receive life-long echocardiographic surveillance to detect cardiomyopathy early. Current risk stratification and surveillance frequency recomme
Autor:
Jacqueline J. Loonen, Livia Kapusta, E.A.M Feijen, H. J. H. van der Pal, E. van Dulmen-den Broeder, Yigal M. Pinto, Jan M. Leerink, L. C. M. Kremer, A C de Vries, Wouter E.M. Kok, Marloes Louwerens, Annelies M. C. Mavinkurve-Groothuis, A. B. Versluys, W.J.E. (Wim) Tissing, M.M. van den Heuvel-Eibrink
Publikováno v:
European Heart Journal. 41
Introduction Plasma biomarkers may aid in the surveillance for anthracycline-induced cardiomyopathy (ACM) in long-term childhood cancer survivors and provide insight into the pathophysiological mechanisms involved. In this pilot study, we aimed to id
Autor:
Jacqueline J. Loonen, W.J.E. (Wim) Tissing, Cécile M. Ronckers, Gertjan L. Kaspers, H. J. H. van der Pal, M.M. van den Heuvel-Eibrink, L. C. M. Kremer, W. van Dorp, Birgitta Versluys, Dorine Bresters, Catharina C. M. Beerendonk, C.B. Lambalk, E. van Dulmen-den Broeder, A. Overbeek, M. van Dijk, F.E. van Leeuwen, M. van den Berg
Publikováno v:
Journal of Cancer Research and Clinical Oncology, 146, 1451-1462
van Dijk, M, van Leeuwen, F E, Overbeek, A, Lambalk, C B, van den Heuvel-Eibrink, M M, van Dorp, W, Tissing, W J, Kremer, L C, Loonen, J J, Versluys, B, Bresters, D, Ronckers, C M, van der Pal, H J, Beerendonk, C C M, Kaspers, G J L, van Dulmen-den Broeder, E & van den Berg, M H 2020, ' Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors : results of the DCOG LATER-VEVO study ', Journal of Cancer Research and Clinical Oncology, vol. 146, no. 6, pp. 1451-1462 . https://doi.org/10.1007/s00432-020-03193-y
Journal of Cancer Research and Clinical Oncology, 146, 6, pp. 1451-1462
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 146(6), 1451-1462. Springer Verlag
Journal of cancer research and clinical oncology, 146(6), 1451-1462. Springer Verlag
van Dijk, M, van Leeuwen, F E, Overbeek, A, Lambalk, C B, van den Heuvel-Eibrink, M M, van Dorp, W, Tissing, W J, Kremer, L C, Loonen, J J, Versluys, B, Bresters, D, Ronckers, C M, van der Pal, H J, Beerendonk, C C M, Kaspers, G J L, van Dulmen-den Broeder, E & van den Berg, M H 2020, ' Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors : results of the DCOG LATER-VEVO study ', Journal of Cancer Research and Clinical Oncology, vol. 146, no. 6, pp. 1451-1462 . https://doi.org/10.1007/s00432-020-03193-y
Journal of Cancer Research and Clinical Oncology, 146, 6, pp. 1451-1462
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 146(6), 1451-1462. Springer Verlag
Journal of cancer research and clinical oncology, 146(6), 1451-1462. Springer Verlag
Purpose To evaluate pregnancy rates, time to pregnancy (TTP) and obstetric outcomes in female childhood cancer survivors (CCSs) and to identify specific diagnosis- and treatment-related factors associated with these outcomes. Methods The study is par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::653b5a6b3447e3ff45db6fd811b3cf34
http://hdl.handle.net/2066/220530
http://hdl.handle.net/2066/220530
Autor:
Renée L. Mulder, Edit Bardi, Morven C. Brown, Roderick Skinner, Gisela Michel, Laurent Kremer, Rachael Windsor, Eva Frey, Gill Levitt, H. J. H. van der Pal
Publikováno v:
European journal of cancer (Oxford, England, 54, 64-68. Elsevier Limited
Evidence-based clinical practice guidelines are essential to ensure that childhood cancer survivors at risk of chronic health conditions receive effective long-term follow-up care. However, adult survivors of childhood cancer are not always engaged i
Autor:
Leontien C. M. Kremer, Jacqueline J. Loonen, Annemieke C. Heijboer, Wim J. E. Tissing, Dorine Bresters, M. van den Berg, E. van Dulmen-den Broeder, Michael Hauptmann, A. B. Versluys, Catharina C. M. Beerendonk, Jos W. R. Twisk, M. Van der Heiden-van der Loo, F.E. van Leeuwen, Cécile M. Ronckers, M.M. van den Heuvel-Eibrink, H. J. H. van der Pal, Gertjan J.L. Kaspers, A. Overbeek, Joop S.E. Laven, C.B. Lambalk
Publikováno v:
van den Berg, M H, Overbeek, A, Lambalk, C B, Kaspers, G J L, Bresters, D, van den Heuvel-Eibrink, M M, Kremer, L C, Loonen, J J, van der Pal, H J, Ronckers, C M, Tissing, W J E, Versluys, A B, van der Heiden-van der Loo, M, Heijboer, A C, Hauptmann, M, Twisk, J W R, Laven, J S E, Beerendonk, C C M, van Leeuwen, F E & van Dulmen-den Broeder, E 2018, ' Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve ', Human Reproduction, vol. 33, no. 8, pp. 1474-1488 . https://doi.org/10.1093/humrep/dey229
Human Reproduction, 33(8), 1474-1488. Oxford University Press
Human Reproduction, 33, 8, pp. 1474-1488
Human reproduction (Oxford, England), 33(8), 1474-1488. Oxford University Press
Human Reproduction, 33, 1474-1488
Human Reproduction, 33(8), 1474. Oxford University Press
Human Reproduction, 33(8), 1474-1488. Oxford University Press
Human Reproduction, 33, 8, pp. 1474-1488
Human reproduction (Oxford, England), 33(8), 1474-1488. Oxford University Press
Human Reproduction, 33, 1474-1488
Human Reproduction, 33(8), 1474. Oxford University Press
Study Question: Which treatment-related factors are (dose-dependently) associated with abnormal hormonal and ultrasound markers of ovarian reserve in female childhood cancer survivors (CCSs)?Summary Answer: Cyclophosphamide, procarbazine, a composite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1ab033ae309e7471eed6a4857101ccb
https://research.vumc.nl/en/publications/32267e2d-a5b9-4962-b824-e90a192c1ccc
https://research.vumc.nl/en/publications/32267e2d-a5b9-4962-b824-e90a192c1ccc
Autor:
Leontien C. M. Kremer, Wim J. E. Tissing, Dorine Bresters, M. van den Berg, M.M. van den Heuvel-Eibrink, F.E. van Leeuwen, C.B. Lambalk, M. van Dijk, Gertjan J.L. Kaspers, Jacqueline J. Loonen, A. Overbeek, Birgitta Versluys, E. van Dulmen-den Broeder, H. J. H. van der Pal
Publikováno v:
Human Reproduction, 33(6), 1167-1174. Oxford University Press
van Dijk, M, van den Berg, M H, Overbeek, A, Lambalk, C B, van den Heuvel-Eibrink, M M, Tissing, W J, Kremer, L C, van der Pal, H J, Loonen, J J, Versluys, B, Bresters, D, Kaspers, G J L, van Leeuwen, F E & van Dulmen-den Broeder, E 2018, ' Reproductive intentions and use of reproductive health care among female survivors of childhood cancer ', Human Reproduction, vol. 33, no. 6, pp. 1167-1174 . https://doi.org/10.1093/humrep/dey058
Human reproduction (Oxford, England), 33(6), 1167-1174. Oxford University Press
Human Reproduction, 33, 6, pp. 1167-1174
Human Reproduction, 33, 1167-1174
Human Reproduction, 33(6), 1167. Oxford University Press
van Dijk, M, van den Berg, M H, Overbeek, A, Lambalk, C B, van den Heuvel-Eibrink, M M, Tissing, W J, Kremer, L C, van der Pal, H J, Loonen, J J, Versluys, B, Bresters, D, Kaspers, G J L, van Leeuwen, F E & van Dulmen-den Broeder, E 2018, ' Reproductive intentions and use of reproductive health care among female survivors of childhood cancer ', Human Reproduction, vol. 33, no. 6, pp. 1167-1174 . https://doi.org/10.1093/humrep/dey058
Human reproduction (Oxford, England), 33(6), 1167-1174. Oxford University Press
Human Reproduction, 33, 6, pp. 1167-1174
Human Reproduction, 33, 1167-1174
Human Reproduction, 33(6), 1167. Oxford University Press
STUDY QUESTION: Do female childhood cancer survivors (CCSs) express a decreased desire to have children and do they use reproductive health care more often compared to women without a history of cancer?SUMMARY ANSWER: Overall, no difference was found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d39cbfaa6c5071016f543ed014a947f
https://pure.eur.nl/en/publications/088b4857-100e-4718-8984-3be8d873a7bc
https://pure.eur.nl/en/publications/088b4857-100e-4718-8984-3be8d873a7bc
Autor:
H. M. van Santen, R.R. van Rijn, H. J. H. van der Pal, S.C. Clement, Leontien C. M. Kremer, S.J.C.M.M. Neggers, Cécile M. Ronckers, M.M. van den Heuvel-Eibrink, Robin P. Peeters, B. L. F. van Eck-Smit, E.J.M. Nieveen van Dijkum, Thera P. Links
Publikováno v:
Cancer Treatment Reviews, 41(10), 925-934. W.B. Saunders
Cancer Treatment Reviews, 41(10), 925. W.B. Saunders Ltd
Cancer Treatment Reviews, 41(10), 925. W.B. Saunders Ltd
Background: Treatment of differentiated thyroid carcinoma (DTC) often involves administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC has favorable outcome and the incidence is increasing, concerns have been rai